Therapeutic Evaluation in a Patient with Gastroenteritis and Acute Abdomen
DOI:
https://doi.org/10.53861/lontarariset.v6i2.579Keywords:
Gastroenteritis, Gastrointestinal Infection, Omeprazole, Ceftriaxone, Fluid Therapy, Patient EducationAbstract
Gastroenteritis is one of the major health problems that is still often found in developing countries, especially in vulnerable groups. This study aims to evaluate pharmacological and non-pharmacological therapy in a 43-year-old female patient diagnosed with gastroenteritis due to infection and accompanied by acute abdomen. This study used a case study approach with the SOAP method, based on medical record data at Tombulilato Hospital, Gorontalo. Initial therapy included rehydration using Ringer Lactate, and administration of Omeprazole, Ondansetron, and Ceftriaxone. Therapy was continued with symptomatic drugs such as Paracetamol, Ketoprofen, and Sucralfate. Daily evaluation showed significant clinical improvement, and the patient was discharged on the fourth day in stable condition after therapy was switched to oral form. This study shows the importance of choosing the right therapy, monitoring patient conditions, and patient education in accelerating recovery. It is recommended to replace Omeprazole with Esomeprazole and Ketoprofen with a combination of Paracetamol-Tramadol to reduce the risk of gastrointestinal side effects.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Alia Nur Lamalani, Widy Susanti Abdulkadir, Annisa Humaira Yusuf, Fajria Indah Hippy, Magfira Susilowati Monoarfa, Rayhan Firman Anasiru, Siti Ruqaiyah Lakoro

This work is licensed under a Creative Commons Attribution 4.0 International License.
Lontara Journal Of Health Science And Technology is licensed under Creative Commons.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International (CC BY 4.0).
The Creative Commons Attribution 4.0 International (CC BY 4.0) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.